nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CA5B—cervicothoracic ganglion—systemic scleroderma	0.146	0.525	CbGeAlD
Dorzolamide—CYP2C9—cardial valve—systemic scleroderma	0.048	0.173	CbGeAlD
Dorzolamide—CA7—digestive system—systemic scleroderma	0.00736	0.0265	CbGeAlD
Dorzolamide—CA12—connective tissue—systemic scleroderma	0.00662	0.0238	CbGeAlD
Dorzolamide—CA9—digestive system—systemic scleroderma	0.00646	0.0233	CbGeAlD
Dorzolamide—CA9—tendon—systemic scleroderma	0.00615	0.0221	CbGeAlD
Dorzolamide—CA14—tendon—systemic scleroderma	0.00583	0.021	CbGeAlD
Dorzolamide—CA12—digestive system—systemic scleroderma	0.00478	0.0172	CbGeAlD
Dorzolamide—CA5B—tendon—systemic scleroderma	0.00408	0.0147	CbGeAlD
Dorzolamide—CA12—lung—systemic scleroderma	0.00399	0.0144	CbGeAlD
Dorzolamide—CA1—digestive system—systemic scleroderma	0.00379	0.0136	CbGeAlD
Dorzolamide—CA5B—lung—systemic scleroderma	0.00358	0.0129	CbGeAlD
Dorzolamide—CA2—connective tissue—systemic scleroderma	0.0034	0.0122	CbGeAlD
Dorzolamide—CA1—lung—systemic scleroderma	0.00316	0.0114	CbGeAlD
Dorzolamide—CA2—smooth muscle tissue—systemic scleroderma	0.00311	0.0112	CbGeAlD
Dorzolamide—CA2—skin of body—systemic scleroderma	0.00307	0.011	CbGeAlD
Dorzolamide—CA4—digestive system—systemic scleroderma	0.00296	0.0107	CbGeAlD
Dorzolamide—CA4—tendon—systemic scleroderma	0.00282	0.0101	CbGeAlD
Dorzolamide—CA4—lung—systemic scleroderma	0.00247	0.0089	CbGeAlD
Dorzolamide—CA2—digestive system—systemic scleroderma	0.00245	0.00883	CbGeAlD
Dorzolamide—CA2—tendon—systemic scleroderma	0.00234	0.00841	CbGeAlD
Dorzolamide—CYP2C9—digestive system—systemic scleroderma	0.00208	0.00747	CbGeAlD
Dorzolamide—CA2—lung—systemic scleroderma	0.00205	0.00738	CbGeAlD
Dorzolamide—CYP3A4—digestive system—systemic scleroderma	0.00158	0.0057	CbGeAlD
Dorzolamide—Chest pain—Lisinopril—systemic scleroderma	0.000814	0.00113	CcSEcCtD
Dorzolamide—Arthralgia—Lisinopril—systemic scleroderma	0.000814	0.00113	CcSEcCtD
Dorzolamide—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000814	0.00113	CcSEcCtD
Dorzolamide—Anxiety—Lisinopril—systemic scleroderma	0.000811	0.00112	CcSEcCtD
Dorzolamide—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000811	0.00112	CcSEcCtD
Dorzolamide—Dyspnoea—Leflunomide—systemic scleroderma	0.00081	0.00112	CcSEcCtD
Dorzolamide—Hypotension—Mycophenolic acid—systemic scleroderma	0.00081	0.00112	CcSEcCtD
Dorzolamide—Discomfort—Lisinopril—systemic scleroderma	0.000805	0.00111	CcSEcCtD
Dorzolamide—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000804	0.00111	CcSEcCtD
Dorzolamide—Dyspepsia—Leflunomide—systemic scleroderma	0.0008	0.00111	CcSEcCtD
Dorzolamide—Vomiting—Mometasone—systemic scleroderma	0.000798	0.00111	CcSEcCtD
Dorzolamide—Dry mouth—Lisinopril—systemic scleroderma	0.000796	0.0011	CcSEcCtD
Dorzolamide—Feeling abnormal—Azathioprine—systemic scleroderma	0.000793	0.0011	CcSEcCtD
Dorzolamide—Rash—Mometasone—systemic scleroderma	0.000791	0.0011	CcSEcCtD
Dorzolamide—Asthenia—Captopril—systemic scleroderma	0.000791	0.0011	CcSEcCtD
Dorzolamide—Dermatitis—Mometasone—systemic scleroderma	0.000791	0.00109	CcSEcCtD
Dorzolamide—Decreased appetite—Leflunomide—systemic scleroderma	0.00079	0.00109	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00079	0.00109	CcSEcCtD
Dorzolamide—Confusional state—Lisinopril—systemic scleroderma	0.000787	0.00109	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000787	0.00109	CcSEcCtD
Dorzolamide—Headache—Mometasone—systemic scleroderma	0.000786	0.00109	CcSEcCtD
Dorzolamide—Insomnia—Mycophenolic acid—systemic scleroderma	0.000784	0.00109	CcSEcCtD
Dorzolamide—Fatigue—Leflunomide—systemic scleroderma	0.000783	0.00108	CcSEcCtD
Dorzolamide—Oedema—Lisinopril—systemic scleroderma	0.000781	0.00108	CcSEcCtD
Dorzolamide—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000781	0.00108	CcSEcCtD
Dorzolamide—Pruritus—Captopril—systemic scleroderma	0.00078	0.00108	CcSEcCtD
Dorzolamide—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000778	0.00108	CcSEcCtD
Dorzolamide—Pain—Leflunomide—systemic scleroderma	0.000777	0.00108	CcSEcCtD
Dorzolamide—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000773	0.00107	CcSEcCtD
Dorzolamide—Somnolence—Mycophenolic acid—systemic scleroderma	0.00077	0.00107	CcSEcCtD
Dorzolamide—Shock—Lisinopril—systemic scleroderma	0.000768	0.00106	CcSEcCtD
Dorzolamide—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000766	0.00106	CcSEcCtD
Dorzolamide—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000763	0.00106	CcSEcCtD
Dorzolamide—Abdominal pain—Azathioprine—systemic scleroderma	0.00076	0.00105	CcSEcCtD
Dorzolamide—Body temperature increased—Azathioprine—systemic scleroderma	0.00076	0.00105	CcSEcCtD
Dorzolamide—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000755	0.00105	CcSEcCtD
Dorzolamide—Diarrhoea—Captopril—systemic scleroderma	0.000754	0.00104	CcSEcCtD
Dorzolamide—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000753	0.00104	CcSEcCtD
Dorzolamide—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000753	0.00104	CcSEcCtD
Dorzolamide—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000752	0.00104	CcSEcCtD
Dorzolamide—Erectile dysfunction—Prednisone—systemic scleroderma	0.000751	0.00104	CcSEcCtD
Dorzolamide—Feeling abnormal—Leflunomide—systemic scleroderma	0.000749	0.00104	CcSEcCtD
Dorzolamide—Fatigue—Mycophenolic acid—systemic scleroderma	0.000747	0.00103	CcSEcCtD
Dorzolamide—Mood swings—Methotrexate—systemic scleroderma	0.000747	0.00103	CcSEcCtD
Dorzolamide—Nausea—Mometasone—systemic scleroderma	0.000745	0.00103	CcSEcCtD
Dorzolamide—Anorexia—Lisinopril—systemic scleroderma	0.000744	0.00103	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000743	0.00103	CcSEcCtD
Dorzolamide—Pain—Mycophenolic acid—systemic scleroderma	0.000741	0.00103	CcSEcCtD
Dorzolamide—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000741	0.00103	CcSEcCtD
Dorzolamide—Weight decreased—Prednisone—systemic scleroderma	0.000738	0.00102	CcSEcCtD
Dorzolamide—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000737	0.00102	CcSEcCtD
Dorzolamide—Hyperglycaemia—Prednisone—systemic scleroderma	0.000735	0.00102	CcSEcCtD
Dorzolamide—Cough—Mycophenolate mofetil—systemic scleroderma	0.000731	0.00101	CcSEcCtD
Dorzolamide—Hypotension—Lisinopril—systemic scleroderma	0.000729	0.00101	CcSEcCtD
Dorzolamide—Dizziness—Captopril—systemic scleroderma	0.000729	0.00101	CcSEcCtD
Dorzolamide—Depression—Prednisone—systemic scleroderma	0.000725	0.001	CcSEcCtD
Dorzolamide—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000724	0.001	CcSEcCtD
Dorzolamide—Urticaria—Leflunomide—systemic scleroderma	0.000722	0.000999	CcSEcCtD
Dorzolamide—Abdominal pain—Leflunomide—systemic scleroderma	0.000718	0.000995	CcSEcCtD
Dorzolamide—Body temperature increased—Leflunomide—systemic scleroderma	0.000718	0.000995	CcSEcCtD
Dorzolamide—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000717	0.000992	CcSEcCtD
Dorzolamide—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000714	0.000989	CcSEcCtD
Dorzolamide—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000713	0.000988	CcSEcCtD
Dorzolamide—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000713	0.000988	CcSEcCtD
Dorzolamide—Myocardial infarction—Prednisone—systemic scleroderma	0.000713	0.000987	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000711	0.000985	CcSEcCtD
Dorzolamide—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000711	0.000985	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.00071	0.000983	CcSEcCtD
Dorzolamide—Hypersensitivity—Azathioprine—systemic scleroderma	0.000709	0.000982	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000709	0.000981	CcSEcCtD
Dorzolamide—Insomnia—Lisinopril—systemic scleroderma	0.000706	0.000978	CcSEcCtD
Dorzolamide—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000705	0.000976	CcSEcCtD
Dorzolamide—Paraesthesia—Lisinopril—systemic scleroderma	0.000701	0.000971	CcSEcCtD
Dorzolamide—Vomiting—Captopril—systemic scleroderma	0.000701	0.000971	CcSEcCtD
Dorzolamide—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000698	0.000966	CcSEcCtD
Dorzolamide—Dyspnoea—Lisinopril—systemic scleroderma	0.000696	0.000964	CcSEcCtD
Dorzolamide—Rash—Captopril—systemic scleroderma	0.000695	0.000962	CcSEcCtD
Dorzolamide—Dermatitis—Captopril—systemic scleroderma	0.000694	0.000962	CcSEcCtD
Dorzolamide—Somnolence—Lisinopril—systemic scleroderma	0.000694	0.000961	CcSEcCtD
Dorzolamide—Headache—Captopril—systemic scleroderma	0.000691	0.000956	CcSEcCtD
Dorzolamide—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00069	0.000955	CcSEcCtD
Dorzolamide—Dyspepsia—Lisinopril—systemic scleroderma	0.000687	0.000952	CcSEcCtD
Dorzolamide—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000685	0.000949	CcSEcCtD
Dorzolamide—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000685	0.000949	CcSEcCtD
Dorzolamide—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000684	0.000947	CcSEcCtD
Dorzolamide—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000684	0.000947	CcSEcCtD
Dorzolamide—Decreased appetite—Lisinopril—systemic scleroderma	0.000679	0.00094	CcSEcCtD
Dorzolamide—Fatigue—Lisinopril—systemic scleroderma	0.000673	0.000932	CcSEcCtD
Dorzolamide—Shock—Mycophenolate mofetil—systemic scleroderma	0.000673	0.000932	CcSEcCtD
Dorzolamide—Hypersensitivity—Leflunomide—systemic scleroderma	0.000669	0.000927	CcSEcCtD
Dorzolamide—Pain—Lisinopril—systemic scleroderma	0.000668	0.000924	CcSEcCtD
Dorzolamide—Bradycardia—Prednisone—systemic scleroderma	0.000664	0.00092	CcSEcCtD
Dorzolamide—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000661	0.000916	CcSEcCtD
Dorzolamide—Diarrhoea—Azathioprine—systemic scleroderma	0.000658	0.000912	CcSEcCtD
Dorzolamide—Nausea—Captopril—systemic scleroderma	0.000655	0.000907	CcSEcCtD
Dorzolamide—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000652	0.000903	CcSEcCtD
Dorzolamide—Asthenia—Leflunomide—systemic scleroderma	0.000652	0.000903	CcSEcCtD
Dorzolamide—Hallucination—Prednisone—systemic scleroderma	0.000649	0.000899	CcSEcCtD
Dorzolamide—Feeling abnormal—Lisinopril—systemic scleroderma	0.000643	0.000891	CcSEcCtD
Dorzolamide—Pruritus—Leflunomide—systemic scleroderma	0.000643	0.00089	CcSEcCtD
Dorzolamide—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000639	0.000885	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000638	0.000884	CcSEcCtD
Dorzolamide—Dysuria—Methotrexate—systemic scleroderma	0.000637	0.000882	CcSEcCtD
Dorzolamide—Dizziness—Azathioprine—systemic scleroderma	0.000636	0.000881	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000633	0.000877	CcSEcCtD
Dorzolamide—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000628	0.000869	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000623	0.000863	CcSEcCtD
Dorzolamide—Asthenia—Mycophenolic acid—systemic scleroderma	0.000622	0.000861	CcSEcCtD
Dorzolamide—Diarrhoea—Leflunomide—systemic scleroderma	0.000622	0.000861	CcSEcCtD
Dorzolamide—Urticaria—Lisinopril—systemic scleroderma	0.00062	0.000859	CcSEcCtD
Dorzolamide—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000619	0.000857	CcSEcCtD
Dorzolamide—Body temperature increased—Lisinopril—systemic scleroderma	0.000617	0.000855	CcSEcCtD
Dorzolamide—Abdominal pain—Lisinopril—systemic scleroderma	0.000617	0.000855	CcSEcCtD
Dorzolamide—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000614	0.000851	CcSEcCtD
Dorzolamide—Pruritus—Mycophenolic acid—systemic scleroderma	0.000613	0.000849	CcSEcCtD
Dorzolamide—Vomiting—Azathioprine—systemic scleroderma	0.000612	0.000847	CcSEcCtD
Dorzolamide—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00061	0.000844	CcSEcCtD
Dorzolamide—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000608	0.000842	CcSEcCtD
Dorzolamide—Rash—Azathioprine—systemic scleroderma	0.000607	0.00084	CcSEcCtD
Dorzolamide—Dermatitis—Azathioprine—systemic scleroderma	0.000606	0.000839	CcSEcCtD
Dorzolamide—Depression—Methotrexate—systemic scleroderma	0.000606	0.000839	CcSEcCtD
Dorzolamide—Headache—Azathioprine—systemic scleroderma	0.000603	0.000835	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000602	0.000834	CcSEcCtD
Dorzolamide—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000602	0.000834	CcSEcCtD
Dorzolamide—Dizziness—Leflunomide—systemic scleroderma	0.000601	0.000832	CcSEcCtD
Dorzolamide—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000595	0.000823	CcSEcCtD
Dorzolamide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000593	0.000821	CcSEcCtD
Dorzolamide—Conjunctivitis—Methotrexate—systemic scleroderma	0.00059	0.000818	CcSEcCtD
Dorzolamide—Pain—Mycophenolate mofetil—systemic scleroderma	0.000585	0.00081	CcSEcCtD
Dorzolamide—Arrhythmia—Prednisone—systemic scleroderma	0.000583	0.000807	CcSEcCtD
Dorzolamide—Sweating—Methotrexate—systemic scleroderma	0.000582	0.000807	CcSEcCtD
Dorzolamide—Vomiting—Leflunomide—systemic scleroderma	0.000578	0.0008	CcSEcCtD
Dorzolamide—Alopecia—Prednisone—systemic scleroderma	0.000577	0.000799	CcSEcCtD
Dorzolamide—Hypersensitivity—Lisinopril—systemic scleroderma	0.000575	0.000796	CcSEcCtD
Dorzolamide—Dizziness—Mycophenolic acid—systemic scleroderma	0.000573	0.000794	CcSEcCtD
Dorzolamide—Epistaxis—Methotrexate—systemic scleroderma	0.000573	0.000794	CcSEcCtD
Dorzolamide—Rash—Leflunomide—systemic scleroderma	0.000573	0.000793	CcSEcCtD
Dorzolamide—Dermatitis—Leflunomide—systemic scleroderma	0.000572	0.000793	CcSEcCtD
Dorzolamide—Nausea—Azathioprine—systemic scleroderma	0.000571	0.000791	CcSEcCtD
Dorzolamide—Headache—Leflunomide—systemic scleroderma	0.000569	0.000788	CcSEcCtD
Dorzolamide—Erythema—Prednisone—systemic scleroderma	0.000568	0.000787	CcSEcCtD
Dorzolamide—Agranulocytosis—Methotrexate—systemic scleroderma	0.000567	0.000785	CcSEcCtD
Dorzolamide—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000564	0.000781	CcSEcCtD
Dorzolamide—Asthenia—Lisinopril—systemic scleroderma	0.00056	0.000776	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000559	0.000775	CcSEcCtD
Dorzolamide—Pruritus—Lisinopril—systemic scleroderma	0.000552	0.000765	CcSEcCtD
Dorzolamide—Vomiting—Mycophenolic acid—systemic scleroderma	0.000551	0.000763	CcSEcCtD
Dorzolamide—Rash—Mycophenolic acid—systemic scleroderma	0.000546	0.000757	CcSEcCtD
Dorzolamide—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000546	0.000756	CcSEcCtD
Dorzolamide—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000543	0.000752	CcSEcCtD
Dorzolamide—Headache—Mycophenolic acid—systemic scleroderma	0.000543	0.000752	CcSEcCtD
Dorzolamide—Pharyngitis—Methotrexate—systemic scleroderma	0.000541	0.00075	CcSEcCtD
Dorzolamide—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000541	0.000749	CcSEcCtD
Dorzolamide—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000541	0.000749	CcSEcCtD
Dorzolamide—Nausea—Leflunomide—systemic scleroderma	0.00054	0.000747	CcSEcCtD
Dorzolamide—Vision blurred—Prednisone—systemic scleroderma	0.000535	0.000741	CcSEcCtD
Dorzolamide—Diarrhoea—Lisinopril—systemic scleroderma	0.000534	0.00074	CcSEcCtD
Dorzolamide—Visual impairment—Methotrexate—systemic scleroderma	0.000526	0.000728	CcSEcCtD
Dorzolamide—Angioedema—Prednisone—systemic scleroderma	0.000519	0.000719	CcSEcCtD
Dorzolamide—Dizziness—Lisinopril—systemic scleroderma	0.000516	0.000715	CcSEcCtD
Dorzolamide—Erythema multiforme—Methotrexate—systemic scleroderma	0.000516	0.000714	CcSEcCtD
Dorzolamide—Nausea—Mycophenolic acid—systemic scleroderma	0.000515	0.000713	CcSEcCtD
Dorzolamide—Vertigo—Prednisone—systemic scleroderma	0.00051	0.000707	CcSEcCtD
Dorzolamide—Syncope—Prednisone—systemic scleroderma	0.000509	0.000705	CcSEcCtD
Dorzolamide—Tinnitus—Methotrexate—systemic scleroderma	0.000508	0.000704	CcSEcCtD
Dorzolamide—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000504	0.000698	CcSEcCtD
Dorzolamide—Loss of consciousness—Prednisone—systemic scleroderma	0.000499	0.000691	CcSEcCtD
Dorzolamide—Vomiting—Lisinopril—systemic scleroderma	0.000496	0.000687	CcSEcCtD
Dorzolamide—Rash—Lisinopril—systemic scleroderma	0.000492	0.000682	CcSEcCtD
Dorzolamide—Dermatitis—Lisinopril—systemic scleroderma	0.000492	0.000681	CcSEcCtD
Dorzolamide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000491	0.00068	CcSEcCtD
Dorzolamide—Hypertension—Prednisone—systemic scleroderma	0.00049	0.000679	CcSEcCtD
Dorzolamide—Headache—Lisinopril—systemic scleroderma	0.000489	0.000677	CcSEcCtD
Dorzolamide—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000484	0.00067	CcSEcCtD
Dorzolamide—Arthralgia—Prednisone—systemic scleroderma	0.000484	0.00067	CcSEcCtD
Dorzolamide—Anxiety—Prednisone—systemic scleroderma	0.000482	0.000667	CcSEcCtD
Dorzolamide—Alopecia—Methotrexate—systemic scleroderma	0.000482	0.000667	CcSEcCtD
Dorzolamide—Discomfort—Prednisone—systemic scleroderma	0.000478	0.000662	CcSEcCtD
Dorzolamide—Erythema—Methotrexate—systemic scleroderma	0.000475	0.000657	CcSEcCtD
Dorzolamide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000468	0.000648	CcSEcCtD
Dorzolamide—Dysgeusia—Methotrexate—systemic scleroderma	0.000465	0.000644	CcSEcCtD
Dorzolamide—Nausea—Lisinopril—systemic scleroderma	0.000464	0.000642	CcSEcCtD
Dorzolamide—Oedema—Prednisone—systemic scleroderma	0.000464	0.000642	CcSEcCtD
Dorzolamide—Anaphylactic shock—Prednisone—systemic scleroderma	0.000464	0.000642	CcSEcCtD
Dorzolamide—Back pain—Methotrexate—systemic scleroderma	0.000459	0.000636	CcSEcCtD
Dorzolamide—Shock—Prednisone—systemic scleroderma	0.000456	0.000632	CcSEcCtD
Dorzolamide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000452	0.000626	CcSEcCtD
Dorzolamide—Hyperhidrosis—Prednisone—systemic scleroderma	0.000448	0.000621	CcSEcCtD
Dorzolamide—Vision blurred—Methotrexate—systemic scleroderma	0.000447	0.00062	CcSEcCtD
Dorzolamide—Anorexia—Prednisone—systemic scleroderma	0.000442	0.000612	CcSEcCtD
Dorzolamide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000435	0.000602	CcSEcCtD
Dorzolamide—Rash—Mycophenolate mofetil—systemic scleroderma	0.000431	0.000597	CcSEcCtD
Dorzolamide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000431	0.000597	CcSEcCtD
Dorzolamide—Headache—Mycophenolate mofetil—systemic scleroderma	0.000428	0.000593	CcSEcCtD
Dorzolamide—Vertigo—Methotrexate—systemic scleroderma	0.000427	0.000591	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000422	0.000585	CcSEcCtD
Dorzolamide—Insomnia—Prednisone—systemic scleroderma	0.000419	0.000581	CcSEcCtD
Dorzolamide—Paraesthesia—Prednisone—systemic scleroderma	0.000416	0.000577	CcSEcCtD
Dorzolamide—Cough—Methotrexate—systemic scleroderma	0.000414	0.000574	CcSEcCtD
Dorzolamide—Dyspepsia—Prednisone—systemic scleroderma	0.000408	0.000565	CcSEcCtD
Dorzolamide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000406	0.000563	CcSEcCtD
Dorzolamide—Chest pain—Methotrexate—systemic scleroderma	0.000404	0.00056	CcSEcCtD
Dorzolamide—Arthralgia—Methotrexate—systemic scleroderma	0.000404	0.00056	CcSEcCtD
Dorzolamide—Decreased appetite—Prednisone—systemic scleroderma	0.000403	0.000558	CcSEcCtD
Dorzolamide—Fatigue—Prednisone—systemic scleroderma	0.0004	0.000554	CcSEcCtD
Dorzolamide—Discomfort—Methotrexate—systemic scleroderma	0.000399	0.000553	CcSEcCtD
Dorzolamide—Confusional state—Methotrexate—systemic scleroderma	0.000391	0.000541	CcSEcCtD
Dorzolamide—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000387	0.000537	CcSEcCtD
Dorzolamide—Feeling abnormal—Prednisone—systemic scleroderma	0.000382	0.000529	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000379	0.000525	CcSEcCtD
Dorzolamide—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000375	0.000519	CcSEcCtD
Dorzolamide—Anorexia—Methotrexate—systemic scleroderma	0.000369	0.000511	CcSEcCtD
Dorzolamide—Urticaria—Prednisone—systemic scleroderma	0.000368	0.00051	CcSEcCtD
Dorzolamide—Abdominal pain—Prednisone—systemic scleroderma	0.000366	0.000508	CcSEcCtD
Dorzolamide—Body temperature increased—Prednisone—systemic scleroderma	0.000366	0.000508	CcSEcCtD
Dorzolamide—Hypotension—Methotrexate—systemic scleroderma	0.000362	0.000501	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000353	0.000489	CcSEcCtD
Dorzolamide—Insomnia—Methotrexate—systemic scleroderma	0.00035	0.000485	CcSEcCtD
Dorzolamide—Paraesthesia—Methotrexate—systemic scleroderma	0.000348	0.000482	CcSEcCtD
Dorzolamide—Dyspnoea—Methotrexate—systemic scleroderma	0.000345	0.000478	CcSEcCtD
Dorzolamide—Somnolence—Methotrexate—systemic scleroderma	0.000344	0.000477	CcSEcCtD
Dorzolamide—Hypersensitivity—Prednisone—systemic scleroderma	0.000342	0.000473	CcSEcCtD
Dorzolamide—Dyspepsia—Methotrexate—systemic scleroderma	0.000341	0.000472	CcSEcCtD
Dorzolamide—Decreased appetite—Methotrexate—systemic scleroderma	0.000337	0.000466	CcSEcCtD
Dorzolamide—Fatigue—Methotrexate—systemic scleroderma	0.000334	0.000463	CcSEcCtD
Dorzolamide—Asthenia—Prednisone—systemic scleroderma	0.000333	0.000461	CcSEcCtD
Dorzolamide—Pain—Methotrexate—systemic scleroderma	0.000331	0.000459	CcSEcCtD
Dorzolamide—Pruritus—Prednisone—systemic scleroderma	0.000328	0.000454	CcSEcCtD
Dorzolamide—Feeling abnormal—Methotrexate—systemic scleroderma	0.000319	0.000442	CcSEcCtD
Dorzolamide—Diarrhoea—Prednisone—systemic scleroderma	0.000317	0.000439	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000317	0.000439	CcSEcCtD
Dorzolamide—Urticaria—Methotrexate—systemic scleroderma	0.000308	0.000426	CcSEcCtD
Dorzolamide—Dizziness—Prednisone—systemic scleroderma	0.000307	0.000425	CcSEcCtD
Dorzolamide—Abdominal pain—Methotrexate—systemic scleroderma	0.000306	0.000424	CcSEcCtD
Dorzolamide—Body temperature increased—Methotrexate—systemic scleroderma	0.000306	0.000424	CcSEcCtD
Dorzolamide—Vomiting—Prednisone—systemic scleroderma	0.000295	0.000408	CcSEcCtD
Dorzolamide—Rash—Prednisone—systemic scleroderma	0.000292	0.000405	CcSEcCtD
Dorzolamide—Dermatitis—Prednisone—systemic scleroderma	0.000292	0.000404	CcSEcCtD
Dorzolamide—Headache—Prednisone—systemic scleroderma	0.00029	0.000402	CcSEcCtD
Dorzolamide—Hypersensitivity—Methotrexate—systemic scleroderma	0.000285	0.000395	CcSEcCtD
Dorzolamide—Asthenia—Methotrexate—systemic scleroderma	0.000278	0.000385	CcSEcCtD
Dorzolamide—Nausea—Prednisone—systemic scleroderma	0.000275	0.000381	CcSEcCtD
Dorzolamide—Pruritus—Methotrexate—systemic scleroderma	0.000274	0.00038	CcSEcCtD
Dorzolamide—Diarrhoea—Methotrexate—systemic scleroderma	0.000265	0.000367	CcSEcCtD
Dorzolamide—Dizziness—Methotrexate—systemic scleroderma	0.000256	0.000355	CcSEcCtD
Dorzolamide—Vomiting—Methotrexate—systemic scleroderma	0.000246	0.000341	CcSEcCtD
Dorzolamide—Rash—Methotrexate—systemic scleroderma	0.000244	0.000338	CcSEcCtD
Dorzolamide—Dermatitis—Methotrexate—systemic scleroderma	0.000244	0.000338	CcSEcCtD
Dorzolamide—Headache—Methotrexate—systemic scleroderma	0.000243	0.000336	CcSEcCtD
Dorzolamide—Nausea—Methotrexate—systemic scleroderma	0.00023	0.000319	CcSEcCtD
